- Home
- AXR vs EPIX Comparison
AXR vs EPIX Comparison
Compare AXR & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXR
- EPIX
- Stock Information
- Founded
- AXR 1961
- EPIX 2009
- Country
- AXR United States
- EPIX Canada
- Employees
- AXR N/A
- EPIX N/A
- Industry
- AXR Homebuilding
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- AXR Real Estate
- EPIX Health Care
- Exchange
- AXR Nasdaq
- EPIX Nasdaq
- Market Cap
- AXR 188.7M
- EPIX 209.4M
- IPO Year
- AXR N/A
- EPIX N/A
- Fundamental
- Price
- AXR $32.89
- EPIX $1.72
- Analyst Decision
- AXR
- EPIX Hold
- Analyst Count
- AXR 0
- EPIX 4
- Target Price
- AXR N/A
- EPIX $9.50
- AVG Volume (30 Days)
- AXR 20.1K
- EPIX 2.4M
- Earning Date
- AXR 12-09-2024
- EPIX 12-10-2024
- Dividend Yield
- AXR N/A
- EPIX N/A
- EPS Growth
- AXR N/A
- EPIX N/A
- EPS
- AXR 1.76
- EPIX N/A
- Revenue
- AXR $60,171,000.00
- EPIX N/A
- Revenue This Year
- AXR N/A
- EPIX N/A
- Revenue Next Year
- AXR N/A
- EPIX N/A
- P/E Ratio
- AXR $18.41
- EPIX N/A
- Revenue Growth
- AXR 24.69
- EPIX N/A
- 52 Week Low
- AXR $15.88
- EPIX $1.40
- 52 Week High
- AXR $36.21
- EPIX $11.67
- Technical
- Relative Strength Index (RSI)
- AXR 59.55
- EPIX 23.15
- Support Level
- AXR $30.04
- EPIX $1.75
- Resistance Level
- AXR $32.05
- EPIX $1.89
- Average True Range (ATR)
- AXR 1.74
- EPIX 0.19
- MACD
- AXR 0.20
- EPIX -0.10
- Stochastic Oscillator
- AXR 52.97
- EPIX 7.36
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve the obtaining of approvals and the sale of both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.